These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14971488)

  • 1. Complementary use of gas chromatography-mass spectrometry, gas chromatography-atomic emission detection and nuclear magnetic resonance for identification of pharmaceutically related impurities of unknown structures.
    Laniewski K; Vågerö M; Forsberg E; Forngren T; Hagman G
    J Chromatogr A; 2004 Feb; 1027(1-2):93-102. PubMed ID: 14971488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gas chromatography with mass spectrometric, atomic emission and Fourier transform infrared spectroscopic detection as complementary analytical techniques for the identification of unknown impurities in pharmaceutical analysis.
    Laniewski K; Wännman T; Hagman G
    J Chromatogr A; 2003 Jan; 985(1-2):275-82. PubMed ID: 12580495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of multiple impurities in a pharmaceutical matrix using preparative gas chromatography and computer-assisted structure elucidation.
    Codina A; Ryan RW; Joyce R; Richards DS
    Anal Chem; 2010 Nov; 82(21):9127-33. PubMed ID: 20942391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of impurities in acarbose by using an integrated liquid chromatography-nuclear magnetic resonance and liquid chromatography-mass spectrometry approach.
    Novak P; Cindrić M; Tepes P; Dragojević S; Ilijas M; Mihaljević K
    J Sep Sci; 2005 Aug; 28(13):1442-7. PubMed ID: 16158985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.
    Fancy SA; Beckonert O; Darbon G; Yabsley W; Walley R; Baker D; Perkins GL; Pullen FS; Rumpel K
    Rapid Commun Mass Spectrom; 2006; 20(15):2271-80. PubMed ID: 16810707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-technique analytical characterization of a mixture containing chemical-weapons simulant from a munition.
    Brickhouse MD; Creasy WR; Williams BR; Morrissey KM; O'Connor RJ; Durst HD
    J Chromatogr A; 2000 Jun; 883(1-2):185-98. PubMed ID: 10910213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of gas chromatography/quadrupole-Orbitrap mass spectrometry in support of pharmaceutical research and development.
    Baldwin S; Bristow T; Ray A; Rome K; Sanderson N; Sims M; Cojocariu C; Silcock P
    Rapid Commun Mass Spectrom; 2016 Apr; 30(7):873-80. PubMed ID: 26969929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
    Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
    J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tetra-aryl benzene isomers by using preparative gas chromatography with mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallographic methods.
    Rühle CP; Niere J; Morrison PD; Jones RC; Caradoc-Davies T; Canty AJ; Gardiner MG; Tolhurst VA; Marriott PJ
    Anal Chem; 2010 Jun; 82(11):4501-9. PubMed ID: 20441219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forensic Drug Identification, Confirmation, and Quantification Using Fully Integrated Gas Chromatography with Fourier Transform Infrared and Mass Spectrometric Detection (GC-FT-IR-MS).
    Lanzarotta A; Lorenz L; Voelker S; Falconer TM; Batson JS
    Appl Spectrosc; 2018 May; 72(5):750-756. PubMed ID: 29154671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of impurities in a technical chlorpyrifos by gas chromatography with atomic emission detection].
    Ma LX; Chen JP; Zhang Q; Liang XM
    Se Pu; 2001 Sep; 19(5):407-9. PubMed ID: 12545434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive impurity profiling and quantification of Sudan III dyes by gas chromatography/mass spectrometry.
    Hong JY; Park NH; Yoo KH; Hong J
    J Chromatogr A; 2013 Jul; 1297():186-95. PubMed ID: 23726074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of UV-absorbing extractables from rubber closures used in containers of injectable powder and safety assessment of leachables in the drug.
    Wei Y; Wu Y; Zhu T; Li Z; Zhang Y
    J Pharm Biomed Anal; 2017 May; 138():256-266. PubMed ID: 28231528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profiling of a chemical weapon precursor for possible forensic signatures by comprehensive two-dimensional gas chromatography/mass spectrometry and chemometrics.
    Hoggard JC; Wahl JH; Synovec RE; Mong GM; Fraga CG
    Anal Chem; 2010 Jan; 82(2):689-98. PubMed ID: 20014817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.